On the contrary, patients with AD-AD showed an increase in CSF KLK6 levels from T0 to T12 (p = 0.0269), followed by a decrease from T12 to T24 (p = 0.0126) (Fig. 6b). The gene discussed is KLK6; the disease is Alzheimer disease.